Evidence map›Paper›PMID 42064362›Full record

ReviewFrontiers in genetics2026

Brave new RNA world(s): from prebiotic chemistry to gene regulation and RNA technology.

Alexis A Flores-García, Aura Hernandez-Rodriguez, E Isabel López-Brito, Dafne F Nava-Domínguez, Sebastian P Pasapera, R Franchesca Pazos-Murillo, Tonatzin Pineda-Diaz, Alberto Vázquez-Salazar

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexis A Flores-García *Universidad Abierta y a Distancia de México, Undergraduate Program in Biotechnology Engineering, Mexico City, Mexico.
Aura Hernandez-Rodriguez *Departamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
E Isabel López-Brito *Departamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
Dafne F Nava-Domínguez *Departamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
Sebastian P Pasapera *Departamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
R Franchesca Pazos-Murillo *Universidad Abierta y a Distancia de México, Undergraduate Program in Biotechnology Engineering, Mexico City, Mexico.
Tonatzin Pineda-Diaz *Universidad Abierta y a Distancia de México, Undergraduate Program in Biotechnology Engineering, Mexico City, Mexico.
Alberto Vázquez-SalazarDepartamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA has long provided a plausible route by which heredity and catalysis could become linked in early evolution, and the same chemical versatility helps explain why RNA remains central to origin-of-life research, modern cell biology, and biotechnology. This review adopts a plural framing of RNA worlds to connect three regimes: a primordial RNA world constrained by geochemistry, a contemporary RNA world in which RNAs contribute to catalysis and regulation in cells, and an applied RNA world in which RNA is engineered as a programmable tool. Across these regimes, a common logic emerges from the mapping of sequence to structure to function under explicit constraints. In early evolution, cycling, interfaces, and confinement can generate heterogeneous oligomer pools and bias their persistence, whereas the transition toward Darwinian dynamics depends on copying fidelity, strand dynamics, and compartment coupled population structure. In cells and applications, noncoding RNA networks, RNA modifications, and RNA-guided targeting implement specificity in chemically complex environments, while laboratory selection and design must also confront constraints imposed by stability, delivery, and immune sensing. Across contexts, fitness landscapes and tradeoffs between peak performance and robustness provide experimental benchmarks and practical design principles for RNA function.

Indexed as

mRNA vaccinesnoncoding RNAprebiotic chemistryribozymesRNA therapeuticsRNA world hypothesissynthetic biology

Identifiers

PMID42064362
PMCPMC13126052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.